Wave Life Sciences Ltd.(WVE)
Biotechnology
Rare Disease / Orphan Drug
| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership change | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-03-30 | RA Capital Healthcare Fund LP Director, 10% Owner | Purchase | +8,772,496 | +48.19%26,975,505 | $6.23 | $54,624,378 | View SEC filing | |
| 2026-02-27 | Francis Chris See Remarks | Sale | -33,194 | -22.44%61,867 | $15.05 | $499,593 | View SEC filing | |
| 2026-02-11 | Moran Kyle Chief Financial Officer | Sale | -3,588 | -2.60%134,385 | $13.45 | $48,259 | View SEC filing | |
| 2026-02-11 | BOLNO PAUL President and CEO | Sale | -10,480 | -3.66%275,520 | $13.45 | $140,956 | View SEC filing | |
| 2026-02-11 | Francis Chris See Remarks | Sale | -1,883 | -2.95%61,867 | $13.45 | $25,326 | View SEC filing | |
| 2026-02-11 | Vargeese Chandra See Remarks | Sale | -3,228 | -0.78%408,246 | $13.45 | $43,417 | View SEC filing | |
| 2026-01-06 | Francis Chris See Remarks | Sale | -9,375 | -27.27%25,000 | $16.03 | $150,260 | View SEC filing | |
| 2025-12-15 | GSK plc 10% Owner | Purchase | +1,470,000 | +8.76%18,245,691 | $19.00 | $27,930,000 | View SEC filing | |
| 2025-12-10 | Rawcliffe Adrian Director | Sale | -42,000 | -76.78%12,700 | $15.00 | $630,000 | View SEC filing | |
| 2025-12-10 | Wagner Heidi L Director | Sale | -14,000 | -13.48%44,930 | $13.50 | $189,000 | View SEC filing | |
| 2025-12-10 | HENRY CHRISTIAN O Director | Sale | -93,445 | -33.66%12,700 | $14.65 | $1,369,324 | View SEC filing | |
| 2025-12-10 | Tan Aik Na Director | Sale | -134,218 | -37.11%25,400 | $13.58 | $1,823,159 | View SEC filing | |
| 2025-12-10 | Verdine Gregory L. Director | Sale | -20,000 | -6.77%275,217 | $13.47 | $269,461 | View SEC filing | |
| 2025-12-10 | Francis Chris See Remarks | Sale | -441,031 | -52.94%25,000 | $14.57 | $6,427,085 | View SEC filing | |
| 2025-12-10 | Moran Kyle Chief Financial Officer | Sale | -260,036 | -39.44%90,365 | $15.78 | $4,103,979 | View SEC filing | |
| 2025-12-10 | CORRIGAN MARK Director | Sale | -16,115 | -35.87%28,815 | $13.48 | $217,297 | View SEC filing | |
| 2025-11-14 | RA Capital Healthcare Fund LP Director, 10% Owner | Purchase | +1,000 | +0.01%18,203,009 | $6.69 | $6,688 | View SEC filing | |
| 2025-11-14 | Rawcliffe Adrian Director | Sale | -16,115 | -55.93%12,700 | $6.79 | $109,421 | View SEC filing | |
| 2025-08-26 | Verdine Gregory L. Director | Sale | -10,000 | -3.39%285,217 | $10.00 | $100,000 | View SEC filing | |
| 2025-08-26 | BOLNO PAUL President and CEO | Sale | -217,351 | -64.24%121,000 | $10.10 | $2,194,810 | View SEC filing | |
| 2025-08-19 | Tan Aik Na Director | Sale | -21,000 | -34.21%40,388 | $9.25 | $194,250 | View SEC filing | |
| 2025-08-13 | HENRY CHRISTIAN O Director | Sale | -9,670 | -24.60%29,645 | $8.81 | $85,193 | View SEC filing | |
| 2025-08-07 | TAKANASHI KEN Director | Sale | -4,872 | -0.09%5,716,303 | $8.75 | $42,630 | View SEC filing | |
| 2025-08-07 | Tan Aik Na Director | Sale | -1,127 | -6.99%14,988 | $8.75 | $9,861 | View SEC filing | |
| 2025-06-13 | Verdine Gregory L. Director | Sale | -30,000 | -9.60%282,517 | $6.95 | $208,500 | View SEC filing |
1-25 of 103